4

PRIMARY DOCUMENT

Company: INTERPACE BIOSCIENCES, INC.
Filed: March 20, 2017
Period of Report: March 16, 2017
Accession Number: 0001192482-17-000080

View Document ↗ View on SEC.gov ↗